Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Loses Share To J&J; Rebate Program Could Buoy Sales

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific's share of the U.S. drug-eluting stent market fell four percentage points to 55% during the third quarter as the firm failed to stop Johnson & Johnson/Cordis from stealing market share

You may also be interested in...



Kyphon Takes On Vertebroplasty In Pursuit Of Higher Reimbursement

In an effort to stake out higher kyphoplasty reimbursement, Kyphon will begin enrollment by the fourth quarter for a head-to-head trial comparing the spinal treatments vertebroplasty and kyphoplasty

Kyphon Takes On Vertebroplasty In Pursuit Of Higher Reimbursement

In an effort to stake out higher kyphoplasty reimbursement, Kyphon will begin enrollment by the fourth quarter for a head-to-head trial comparing the spinal treatments vertebroplasty and kyphoplasty

J&J Says It Will Continue To Make Acquisitions; Med-Tech Biz Shines In Q4

Johnson & Johnson says it will continue to invest in acquisitions following yet another strong quarter of medical device sales that salvaged its stagnant pharmaceutical business

Related Content

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel